Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEFOPAM Cause Hepatitis acute? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatitis acute have been filed in association with NEFOPAM. This represents 0.2% of all adverse event reports for NEFOPAM.

5
Reports of Hepatitis acute with NEFOPAM
0.2%
of all NEFOPAM reports
0
Deaths
5
Hospitalizations

How Dangerous Is Hepatitis acute From NEFOPAM?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Hepatitis acute Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEFOPAM. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NEFOPAM Cause?

Cholestasis (135) Confusional state (134) Acute kidney injury (130) Hepatocellular injury (107) Hepatic cytolysis (101) Eosinophilia (97) Rash maculo-papular (97) Drug reaction with eosinophilia and systemic symptoms (90) Coma (86) Somnolence (84)

What Other Drugs Cause Hepatitis acute?

ACETAMINOPHEN (626) ATORVASTATIN (254) IBUPROFEN (157) METHOTREXATE (103) SULFAMETHOXAZOLE\TRIMETHOPRIM (93) ENOXAPARIN (90) METFORMIN (90) NIVOLUMAB (90) AMOXICILLIN\CLAVULANATE (89) AMIODARONE (80)

Which NEFOPAM Alternatives Have Lower Hepatitis acute Risk?

NEFOPAM vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG NEFOPAM vs NELARABINE NEFOPAM vs NELFINAVIR NEFOPAM vs NELVUTAMIG NEFOPAM vs NEMOLIZUMAB

Related Pages

NEFOPAM Full Profile All Hepatitis acute Reports All Drugs Causing Hepatitis acute NEFOPAM Demographics